
Dr Agarwal's Health Care IPO was fully subscribed by 1.55 times on the final day of bidding.
Investors bid for over 7 crore shares against the 8.3 crore shares available for subscription.
The surge was driven by QIBs (qualified institutional buyers) whose reserved portion saw a 4.6 times subscription.
However, the retail investor and non-institutional investor categories remained undersubscribed at 0.41 and 0.39 times, respectively.
Dr Agarwal's Health Care outlook
The eye care specialist is currently the largest eye care service provider by revenue, with a 25 per cent market share in the country's eye care service chain market.
Its comprehensive range of services, covering everything from checkups and consultations to surgeries and the sale of optical and pharmaceutical products, further strengthens its position as a dominant player.
Dr Agarwal's Health Care risks
Factors like stiff competition from leading multi-specialty and single-specialty players, as well as a high concentration of its facilities in just two states (Maharashtra and Tamil Nadu), can potentially hamper the company's growth prospects.
To check the company's historical track record, valuation metrics and key financial ratios, visit our full analysis.
Also read: Dr Agarwal's Health Care IPO Day 2: Latest subscription update







